SOM Biotech achève le processus de recrutement de l'étude de phase IIb sur le traitement de la chorée dans la maladie de Huntington

SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical […]